NEW JAPAN FUND WILL PROMOTE TROPICAL MEDICINE DEVELOPMENT
January 1st, 2014
THE JAPANESE pharma sector may have previously lagged behind its counterparts in Europe and north America helping the very poorest people in the developing world, but the enthusiasm with which five of Japan's biggest pharmaceutical companies have embraced the Global Health Innovative Technology (GHIT) Fund indicates a sea change in policy.Set up in early 2013, the Tokyo-based fund is specifically designed to push Japanese firms' considerable technologies and expertise in developing innovations for a range of infectious diseases, including HIV/AIDS, malaria, ...
Full access to this article can be arranged with permission from the client that first ordered it. Please contact us to request access. Entries are uploaded to our archive at least one year after being published by a client – free access is restricted to International News Services journalists for background research only. The article date indicates when copy was filed to a client, not when posted to this archive. Upon client requests, International News Services will remove such articles from the archive or not upload them in the first place. They are included to demonstrate the breadth of topics undertaken by the agency and also to help promote clients’ coverage.